About Medical Care Technologies Inc.
We are a Nevada incorporated medical services and technology company headquartered in Beijing, China. We are engaged principally in the business of i) opening and operating private health and wellness clinics for children in China; ii) developing and maintaining online secure medical information systems used by hospitals and other healthcare institutions and; iii) selling pharmaceutical, nutraceutical and herbal products online and in our proposed private healthcare clinics. Our current and planned operations consist of three business segments: Children's Medical Clinics, Medical Management Software Systems, and Pharmaceutical and Nutraceutical Products.
In January 2010, we signed an Asset Acquisition Agreement ("Asset Agreement") with Great Union Corporation ("Great Union"). In consideration of the issuance of 57, 300,000 shares of our common stock, we acquired Great Union's technologies associated with the development and maintenance of secure information systems which increase access to medical resources services, education and wellness, pharmaceutical and nutraceutical products.
Our main mission now is to open and operate private children's health & wellness clinics throughout China. Concurrent with, and in addition to the clinics we operate, it is our plan to add to our bottom revenue line by offering affordable, standardized and secure software information systems to electronically connect healthcare providers, academic institutions, pharmaceutical and nutraceutical companies, alternative health companies and individual consumers with healthcare information, products and services in China. We aim to generate e-management revenues and nutraceutical and pharmaceutical product distribution revenues.
Our planned products and/services also constitute a healthcare delivery and wellness site; dedicated to helping Chinese consumers live healthier, more balanced lives. Further information on the Company's filings can be found at www.sec.gov.
Medical Care Technologies Inc.'s common stock is traded on the OTC Bulletin Board Markets under the symbol "MDCE".
Extensive Research & Development is underway for entry into China to establish a private Children's health clinic in Beijing.
MDCE's is planning as three-prong strategic entry into the China healthcare industry. The timing as an early entrant provides a first-mover advantage and secures the opportunity to establish a strong and firm footing in the lucrative market which to date is relatively untapped by other private foreign health organisations.
By focusing on the children and healthcare segments is a competitive advantage given the huge emphasis China places on the health and well-being of their children and on the next generation.
The second prong is that MDCE will set up a pharmacy modeled in the style of Hong Kong pharmacies, suited to the East Asian needs and tastes. The pharmacy as an extension of the children's healthcare services is a huge business advantage and provides future opportunities for business development.
The third prong is to establish a call centre to provide health and wellness information to callers and customers. MDCE is in dialogue with several large call centre operations and will evaluate which company has the best fit. This compliments the base healthcare operation as a value-added service.
By securing a cross section of healthcare services - clinical, retail and communication - the company is positioned to be a leader in the private sector of China's healthcare industry.
MDCE has several products that place it among the leaders in developing healthcare information technology.
MedSuite Technology. This is a management information system enabling healthcare professionals to securely exchange patient information electronically such as charts providing them with greater efficiency and reduced costs.
Telehealth Suite. This product is focused on providing the consumer with services such as viewing x-rays and lab results, making appointments, reviewing and monitoring health records and history and general medical information. The Company plans to introduce add-on services and the first of which is a Continuous Glucose Monitoring application for diabetic patients.
MDCE's Research & Development is focusing on:
- mobile access by physicians to patients' readings and records;
- cellular transmissions of clients' health status to caregivers and;
- medication monitoring in a secured environment
A key advantage as a private healthcare company, the Company will be able to offer advertising and marketing of physician approved/recommended medical and wellness products within the secured portals clinical users and patients use to access the electronic medical information.